My Learning Cart
?
Categories
Account

Which biotech company launched a new platform in 2022 to accelerate the discover

₹0.0
Login to Download
  • 📥 Instant PDF Download
  • ♾ Lifetime Access
  • 🛡 Secure & Original Content

What’s inside this PDF?

Question: Which biotech company launched a new platform in 2022 to accelerate the discovery of RNA-targeted therapies?

Options:

  1. Moderna
  2. BioNTech
  3. Arcturus Therapeutics
  4. CureVac

Correct Answer: Arcturus Therapeutics

Solution: 

In 2022, BioNTech launched a new platform aimed at accelerating the discovery of RNA-targeted therapies, enhancing their research capabilities.

Which biotech company launched a new platform in 2022 to accelerate the discover

Practice Questions

Q1
Which biotech company launched a new platform in 2022 to accelerate the discovery of RNA-targeted therapies?
  1. Moderna
  2. BioNTech
  3. Arcturus Therapeutics
  4. CureVac

Questions & Step-by-Step Solutions

Which biotech company launched a new platform in 2022 to accelerate the discovery of RNA-targeted therapies?
  • Step 1: Identify the year mentioned in the question, which is 2022.
  • Step 2: Look for biotech companies that launched new platforms in that year.
  • Step 3: Find out which company specifically focused on RNA-targeted therapies.
  • Step 4: Confirm that BioNTech is the company that launched a new platform in 2022.
  • Step 5: Understand that this platform is designed to enhance research capabilities for RNA-targeted therapies.
No concepts available.
Soulshift Feedback ×

On a scale of 0–10, how likely are you to recommend The Soulshift Academy?

Not likely Very likely
Home Practice Performance eBooks